Navigation Links
Zithromax Arrhythmia and Sudden Death Cases Allegations Update: Resource4thePeople Reports FDA Issued Warning Letter to Manufacturer over False and Misleading Information
Date:8/8/2013

San Diego, CA (PRWEB) August 08, 2013

http://www.resource4thepeople.com/defectivedrugs/Zithromax-lawsuits.html

Resource4thePeople announced today its latest update for consumers seeking information about the possibility of life-threatening negative side effects from popular antibiotics Zithromax and Zmax SR as outlined by the Food and Drug Administration.*

The latest information involves a strongly worded warning letter** sent to the medications' manufacturer, Pfizer Inc., over language federal officials described as "false" and "misleading" in a brochure that the company sent out promoting the antibiotics.

The contents of the June, 19, 2012 letter were found during a recent check of FDA records by Resource4thePeople, whose national team of attorneys are offering free consultations to consumers who allegedly suffered serious heart problems from the use of the antibiotics.

"This warning letter from high-ranking FDA officials calls into question the honesty and marketing methods of Pfizer in promoting medicines that the FDA earlier had warned consumers and health care professionals about over life-threatening heart problems," said Resource4thePeople.

"In addition to announcing these free consultations about possible legal options to seek compensation for the loss of a loved one, medical costs, loss of wages, pain and suffering and other expenses, Resource4thePeople also will continue to provide updates about new developments involving these medications."

In its warning letter the FDA criticized a brochure issued by Pfizer for the medications and made the following finding:

"The brochure is false or misleading because it omits and minimizes important risk information, makes unsubstantiated superiority claims, omit
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. D'Oliveira & Associates Now Offers a No Win No Fee Promise in Zithromax Cases
2. Zithromax Arrhythmia and Sudden Death Allegation Lawsuits Now Being Investigated by Resource4thePeople Lawyers
3. Zithromax Arrhythmia and Sudden Death Allegation Claims Now Being Accepted by Resource4thePeople Lawyers
4. Rottenstein Law Group Notes Medical Journal Article Advising Doctors To Use Caution When Prescribing Zithromax and Other Antibiotics
5. 2013 Alleged Zithromax Arrhythmia and Sudden Death Cases Update: Canadian Health Officials Issue Warning
6. Rottenstein Law Group LLP Announces Launch of Zithromax Lawsuit Center
7. Fine tuning cardiac ablation could lead to quicker results for patients with arrhythmias
8. ESC analysis reveals arrhythmia treatment gaps between Eastern and Western Europe
9. Predicting risk of arrhythmias and sudden cardiac death: Theres a computer model for that
10. Researchers use iPSCs to define optimal treatment for managing life-threatening arrhythmias
11. Arrhythmia drug may increase cancer risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... ... July 01, 2015 , ... There is nothing ... have been arguing over laws governing sexuality since the first Pilgrims landed at ... historical comparative biography by Cindy Safronoff reveals. Crossing Swords: Mary Baker Eddy vs. ...
(Date:7/1/2015)... ... 2015 , ... DIC Corporation today announced the on-schedule completion ... food coloring. Construction of the plant, which is located on the site of ... May 2014. After commissioning, commercial production is expected to begin in September. A ...
(Date:7/1/2015)... ... July 01, 2015 , ... Summer recess has a whole new meaning. Thanks ... chins with plastic surgery when they’re looking for a boost in self-esteem. According to ... were performed on patients ages 19 and younger in 2012, an increase from previous ...
(Date:7/1/2015)... ... July 01, 2015 , ... As if mood swings, cramps and ... significant number of women: leg pain. Northeast Houston Vein Center is offering tips on ... of venous reflux disease, is underdiagnosed and often overlooked. Many women experience the tiredness, ...
(Date:7/1/2015)... ... 2015 , ... Scoliosis is a disorder in which the normally straight vertical line of the ... 3 percent of the population, or an estimated 6 to 9 million people. While it ... ages of 10 and 15. Most types of scoliosis are more common in girls than ...
Breaking Medicine News(10 mins):Health News:Biography by Cindy Safronoff to be Released July 4 Explores an 1870s Marriage Debate Over Women’s Rights and the Implications of the American Revolution for Sexuality 2Health News:Biography by Cindy Safronoff to be Released July 4 Explores an 1870s Marriage Debate Over Women’s Rights and the Implications of the American Revolution for Sexuality 3Health News:Biography by Cindy Safronoff to be Released July 4 Explores an 1870s Marriage Debate Over Women’s Rights and the Implications of the American Revolution for Sexuality 4Health News:DIC Strengthens Its Position as the Global Leader for Natural Blue Food Coloring 2Health News:DIC Strengthens Its Position as the Global Leader for Natural Blue Food Coloring 3Health News:Top Manhattan Facial Plastic Surgeon Dr. Sam Rizk Comments on Teen Surgery Trends 2Health News:Top Manhattan Facial Plastic Surgeon Dr. Sam Rizk Comments on Teen Surgery Trends 3Health News:Northeast Houston Vein Center Offers Tips for Women with Leg Pain 2Health News:Northeast Houston Vein Center Offers Tips for Women with Leg Pain 3Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 2Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 3Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 4
... Health System Bargaining in Bad Faith, OAKLAND, Calif., ... California by the Daughters of,Charity Health System are planning ... by SEIU United Healthcare Workers-West have been,bargaining a new ... refused to make any economic proposals, and is attempting ...
... WAKEFIELD, MA, Aug. 15 /PRNewswire-FirstCall/ - NUCRYST,Pharmaceuticals, a ... and inflammation, today announced that on August 14, ... stating that, for the last,30 consecutive trading days, ... market value of publicly held shares ("MVPHS") of ...
... The Hereditary Disease Foundation,(HDF) is extremely pleased ... or tetrabenazine, for the treatment of chorea associated,with ... of disability and death in patients with,Huntington,s disease. ... can,prevent Huntington,s disease patients from walking, talking, working,watching ...
... Administration today approved tetrabenazine, the first drug approved for ... a fatal, inherited neurodegenerative disorder for which there is ... an advisory panel unanimously voted to advise FDA to ... The drug is already widely used in Europe, Canada ...
... to multiply in a dangerously abnormal way, a series of ... Now, in research to appear in the August 15 issue ... figured out a way in mice to amplify the signals ... a protein that normally helps cells to avoid self-destruction. , ...
... with MYA Cosmetic Surgery. , ... London, UK (PRWEB) August 15, 2008 -- X Factor ... liposuction with http://www.mya.co.uk/ [MYA Cosmetic Surgery]. The 36 year old, ... of her surgery with MYA and in total has lost 6 inches from ...
Cached Medicine News:Health News:NUCRYST Receives Deficiency Notice from NASDAQ 2Health News:NUCRYST Receives Deficiency Notice from NASDAQ 3Health News:FDA approves first drug for Huntington's disease 2Health News:FDA approves first drug for Huntington's disease 3Health News:FDA approves first drug for Huntington's disease 4Health News:By amplifying cell death signals, scientists make precancerous cells self-destruct 2Health News:X Factor's Niki Evans Amazing Cosmetic Surgery Success 2Health News:X Factor's Niki Evans Amazing Cosmetic Surgery Success 3
(Date:7/1/2015)... Ill. , July 1, 2015 ... nationwide group of state and regional professional rheumatology ... survey of rheumatologists that explored perceptions of biosimilars ... on patients. Biosimilars are medicines ... biologic medicines. They are notably different from generic ...
(Date:7/1/2015)... 1, 2015 Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... corporate presentation at the Cantor Fitzgerald Healthcare Conference in ... Russell Cox , executive vice president and chief ... a business and financial update on Wednesday, July 8, 2015 ... A live audio webcast of the presentation may be ...
(Date:7/1/2015)... , July 1, 2015 ContraVir Pharmaceuticals, ... on the development and commercialization of targeted antiviral therapies, ... Fitzgerald Inaugural Healthcare Conference taking place in ... at Le Parker Meridien Hotel. ... overview of the Company,s business during his live presentation ...
Breaking Medicine Technology:Survey Of Rheumatologists Nationwide Regarding Biosimilars Highlights Need For More Robust FDA Standards 2Jazz Pharmaceuticals to Present at Cantor Fitzgerald Healthcare Conference on July 8 2ContraVir to Present at Cantor Fitzgerald Inaugural Healthcare Conference 2
... 3 Glufosfamide and Phase 2 Glufosfamide Plus ... Gemcitabine Clinical Trials to be Presented, REDWOOD CITY, Calif., ... announced two presentations,regarding its oncology product candidate glufosfamide. The presentations,will ... held,September 23 to 27, 2007, at the International Conference Center ...
... First Hsp90 Inhibitor to Enter Registration Trials, HAYWARD, ... ) today announced that it has successfully,reached a binding ... the design of its TIME-1 clinical trial, a pivotal ... treatment for patients with,multiple myeloma. Through the FDA,s Special ...
Cached Medicine Technology:Threshold Pharmaceuticals Announces Two Presentations on Glufosfamide at the 2007 European Cancer Conference (ECCO) 2Threshold Pharmaceuticals Announces Two Presentations on Glufosfamide at the 2007 European Cancer Conference (ECCO) 3Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 2Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 3Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 4Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 5Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 6Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 7
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: